ResMed

ResMed

Organization

Heard in 12 episodes across 5 shows since Oct 2025

ResMed Inc. is a medical equipment and health technology company headquartered in San Diego, California, and founded in Australia. It develops cloud-connected devices and software for sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions, including CPAP systems, masks, ventilators, and out-of-hospital care solutions.

Discussed inMarkets100%

Episodes

12
across 5 shows

This week

0
episodes on 0 shows

Expert statements

3
1 positive · 1 negative

Share of the conversation

Mentions of ResMed per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Sep 180.02‰2
Oct 250.01‰1
Nov 120.01‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when ResMed comes up on a podcast

One email a week at most, with the new episodes that mention ResMed. Free, no account needed, unsubscribe in one click.

What experts have said about ResMed

3 statements · 1 positive · 1 negative · 1 mixed

  1. Chinese competitors selling similar devices at half price threaten ResMed.

    “The main issue for us is that The devices they make, well, there's some Chinese competitors that make very similar looking devices that seem to do pretty much the same and they sell them for half the price. So I'm very worried about Chinese manufacturing competition”

    Listen at 24:49

    Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunity
  2. ResMed remains a long-term compounder despite weak market sentiment.

    “it's a continued compounder ResMed, but the market seems out of love with it still.”

    Listen at 10:32

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  3. Jim CramerPositiveOct 6, 2025· Mad Money w/ Jim Cramer

    ResMed is reporting strong results and its stock has risen 23% this year.

    “If you want to play sleep apnea, Resma has been still putting up good numbers, which is why that stock's up 23% for the year.”

    Listen at 35:06

    Open the episode · Mad Money w/ Jim Cramer 10/6/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

12 episodes featuring ResMed, newest first